FDA warns against unapproved GLP-1 drugs for weight loss
The Food and Drug Administration (FDA) has issued a warning regarding the use of unapproved versions of glucagon-like peptide-1 (GLP-1) receptor agonist drugs, which are often used for weight loss. Read More »
Alerts Sign-up